G1 Therapeutics Nets Seed Venture Capital
Friday, September 21, 2012 5:57:00 AM PDT | VentureDeal
Chapel Hill, North Carolina -- Biotechnology company G1 Therapeutics (no website) has landed $600,000 in early-stage financing.
G1 is a stealth stage company that wants to commercialize technology spun out from UNC-Chapel Hill.
Hatteras Venture Partners made the investment.
The company said it would use the funding to accelerate its drive-development efforts.
Email Page | Print Page